课题基金 / 基金详情

USE OF MUTANTS TO STUDY S. MUTANS PATHOGENICITY

USE OF MUTANTS TO STUDY S. MUTANS PATHOGENICITY
利用突变体研究变异链球菌致病性
批准号:
3220271
负责人:
ROY CURTISS III
金额:
$22.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-08-01 至 1990-07-31

项目摘要

项目成果

ROY CURTISS III的其他基金

相似基金

相关文献

中文摘要
翻译
我们的长期目标是了解数量,控制和
英文摘要
Our long-term objective is to understand the number, control and interactions of all gene products involved in the various stages leading to Steptococcus mutans pathogenicity including sucrose-independent and dependent adherence, aggregation, complex carbohydrate biosynthesis, and carbohydrate metabolism and acid production. Our current efforts are directed at those gene products which influence those processes which occur on the S. mutans cell surface. Specifically, we will: 1) further characterize and establish the mechanism by which a water-soluble glucan produced by an adherence-defective dextranase-negative S. mutans mutant inhibits plaque formation and cariogenicity of wild-type S. mutans strains, 2) further characterize the roles of the SpaA protein in S. mutans virulence and elucidate its relationship to dextranase and glucan-binding, 3) isolate and characterize mutants that are defective in being agglutinated by the agglutinin from Persea americana, 4) study the function and regulation of the gtfA gene product using insertional inactivation of and lacZ fusions with the gtfA gene cloned on a shuttle plasmid vector, 5) construct a Tn5 or Tn903 derivative in which kanamycin-resistance and transposition will be under the control of a promoter functioning in S. mutans and in Escherichia coli, 6) isolate new mutants of S. mutans with genetic defects in the synthesis and placement of known protein products by (i) introducing defective S. mutans genes that had been previously cloned into and characterized in E. coli strains and (ii) selecting mutants for the absence of cell surface proteins by using antibodies against specific S. mutans gene products expressed by E. coli recombinant clones, 7) characterize both existing and newly isolated mutants for (i) presence of cell surface protein products using immunological techniques and antisera raised against such proteins expressed by E. coli recombinants, (ii) ability to adhere, aggregate and produce acid, (iii) presence of enzymes such as glucosyltransferase, fructosyltransferase, dextranase and invertase and (iv) ability to complement each other for adherence, aggregation and plaque formation during mixed cultivation, and 8) evaluate the virulence of mutants alone and in combination in gnotobiotic rats.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Isolation and characterization of mutants of Streptococcus mutans using selective removal of wild-type cells by agglutination with an agglutinin from Persea americana.
通过与来自美洲鲈的凝集素进行凝集选择性去除野生型细胞,对变形链球菌突变体进行分离和表征。
DOI: --
发表时间: 1987
期刊: Acta microbiologica Polonica
影响因子: --
作者: [Curtiss3rd,R, Pearce,C, Pollack,J, Murchison,HM]
通讯作者: Murchison,HM
In vitro inhibition of adherence of Streptococcus mutans strains by nonadherent mutants of S. mutans 6715.
变形链球菌 6715 的非贴壁突变体对变形链球菌菌株的贴壁的体外抑制。
DOI: 10.1128/iai.50.3.826-832.1985
发表时间: 1985
期刊: Infection and immunity
影响因子: 3.1
作者: [Murchison,H, Larrimore,S, Curtiss3rd,R]
通讯作者: Curtiss3rd,R
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents
海外基金